These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22646248)

  • 1. Focusing on the patient: impact of new UK guidelines on treatment of chronic hepatitis C.
    Ramachandran P; Hayes PC
    Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):259-61. PubMed ID: 22646248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Targeted against every genotype].
    Urban & Vogel
    MMW Fortschr Med; 2015 Apr; 157(6):34. PubMed ID: 26015198
    [No Abstract]   [Full Text] [Related]  

  • 3. UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients.
    Ramachandran P; Fraser A; Agarwal K; Austin A; Brown A; Foster GR; Fox R; Hayes PC; Leen C; Mills PR; Mutimer DJ; Ryder SD; Dillon JF
    Aliment Pharmacol Ther; 2012 Mar; 35(6):647-62. PubMed ID: 22296568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment efficacy and safety in elderly genotype 1b chronic hepatitis C patients with high viral load].
    Nishikawa H
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():209-13. PubMed ID: 26845932
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral therapy with nucleotide polymerase inhibitors for chronic hepatitis C.
    Kumar S; Jacobson IM
    J Hepatol; 2014 Nov; 61(1 Suppl):S91-7. PubMed ID: 25443349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Similar poor response in genotype 4 chronic Hepatitis C treatment with interferon and ribavirin compared with genotype 1 treatment].
    Pérez Mota A; Graus J; García Flores MA; Blanco M; Pérez-Muñoz C; Villalgordo C; Rodero R
    Rev Esp Enferm Dig; 2003 Mar; 95(3):238-9. PubMed ID: 12760714
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations for the treatment of chronic genotype 1 hepatitis C virus infection].
    Silva MO; Ridruejo E; Galdame O; Bessone F; Colombato L; Daruich J; Fainboim H; Fassio E; Fay F; Frider B; Gadano A; Galoppo MC; González J; Tanno H; Terg R; Villamil F; ;
    Acta Gastroenterol Latinoam; 2012 Sep; 42(3):234-49. PubMed ID: 23214356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic hepatitis C].
    Fehér J; Lengyel G
    Orv Hetil; 2004 May; 145(20):1065-7. PubMed ID: 15202329
    [No Abstract]   [Full Text] [Related]  

  • 9. Short treatment to patients with genotype 2 or 3.
    Dalgard O; Mangia A
    Hepatology; 2008 Aug; 48(2):694. PubMed ID: 18666251
    [No Abstract]   [Full Text] [Related]  

  • 10. Qualitative analysis of patient-centered decision attributes associated with initiating hepatitis C treatment.
    Zuchowski JL; Hamilton AB; Pyne JM; Clark JA; Naik AD; Smith DL; Kanwal F
    BMC Gastroenterol; 2015 Oct; 15():124. PubMed ID: 26429337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of patients infected with chronic hepatitis C genotype 2 and 3: more data, more questions?
    Graziadei IW; Vogel W
    Hepatology; 2009 Feb; 49(2):345-7. PubMed ID: 19177579
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcome of antiviral therapy in Egyptian Hepatitis C Virus (HCV) genotype 4 patients with advanced liver fibrosis.
    el-Khattib AA; Abdelhakam SM; Ghoraba DM; Ibrahim WA; Sayed MM
    Eur J Intern Med; 2012 Jan; 23(1):e34-5. PubMed ID: 22153547
    [No Abstract]   [Full Text] [Related]  

  • 13. Pegylated interferon treatment in HCV genotype 2 and 3 patients refractory to conventional interferon.
    Aziz S
    J Coll Physicians Surg Pak; 2012 Oct; 22(10):615-6. PubMed ID: 23058141
    [No Abstract]   [Full Text] [Related]  

  • 14. Current Treatment Options in Patients with Hepatitis C Virus Genotype 6.
    Nguyen NH; Nguyen MH
    Gastroenterol Clin North Am; 2015 Dec; 44(4):871-81. PubMed ID: 26600225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C Virus: Current and Evolving Treatments for Genotypes 2 and 3.
    Ampuero J; Romero-Gómez M
    Gastroenterol Clin North Am; 2015 Dec; 44(4):845-57. PubMed ID: 26600223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9.
    Nguyen MH; Keeffe EB
    Rev Gastroenterol Disord; 2004; 4 Suppl 1():S14-21. PubMed ID: 15184820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C.
    Liu SS; Schneekloth TD; Talwalkar JA; Kim WR; Poterucha JJ; Charlton MR; Wiesner RH; Gross JB
    J Clin Gastroenterol; 2010 Sep; 44(8):e178-85. PubMed ID: 20495464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3.
    Tapper EB; Afdhal NH
    J Viral Hepat; 2013 Oct; 20(10):669-77. PubMed ID: 24010641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEN viruses and treatment response in chronic hepatitis C virus.
    Enomoto M; Nishiguchi S
    Lancet; 2002 May; 359(9319):1780-1. PubMed ID: 12049898
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C Virus: Current and Evolving Treatments for Genotype 4.
    Asselah T; Bourlière M
    Gastroenterol Clin North Am; 2015 Dec; 44(4):859-70. PubMed ID: 26600224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.